Compare Shell PLC (SHEL) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Shell PLC vs TransMedics Group Inc — how do they compare? Shell PLC trades at $87.12 (market cap $235.24B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: Shell PLC is far larger — about 92.6× TransMedics Group Inc's market cap, and Shell PLC pays a 3.63% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| SHEL | TMDX | |
|---|---|---|
Market Cap | $235.24B | $2.54B |
Sector | Energy | Technology |
52-Week High | $94.15 | $150.42 |
52-Week Low | $70.31 | $61.99 |
Enterprise Value | $287.77B | $2.94B |
Dividend Yield | 3.63% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Shell PLC
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.7 million barrels of liquids and 8.7 billion cubic feet of natural gas per day. At year-end 2021, reserves stood at 9.2 billion barrels of oil equivalent, 50% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.8 mmb/d located in the Americas, Asia, Africa, and Europe and sells 15 mtpa of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
Read more on SHEL →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
